论文部分内容阅读
目的观察芪苈强心胶囊和万爽力联用治疗慢性充血性心力衰竭的疗效。方法选择2006年5月至2007年6月在解放军第406医院住院的90例慢性充血性心力衰竭患者,均符合美国心脏病协会诊断标准,按NYHA 分级:心功能Ⅳ级18例,Ⅲ级40例,Ⅱ级32例。按入院顺序随机分为2组,各45例,对照组采用常规药物治疗,给予限盐、休息、利尿剂、洋地黄制剂、氧疗等治疗。治疗组在常规治疗基础上给予芪苈强心胶囊4粒,每日3次,万爽力20 mg,每日3次。持续应用1个月。分别检测心率(HR)、左室射血分数(LVEF)、左室舒张末期内径(LVEDd),每搏量(SV)、心脏指数(CI),并观察心功能变化。结果与对照组比较,治疗组可使 HR 减慢,LVEF、SV、CI 增加,LVEDd 减少,心功能改善(P<0.01),且治疗期间未出现明显不良反应。结论芪苈强心胶囊联用万爽力治疗治疗慢性充血性心力衰竭安全有效。
Objective To observe the effect of Qili Qiangxin Capsule and Wanzhuangli combined therapy on chronic congestive heart failure. Methods From May 2006 to June 2007, 90 patients with chronic congestive heart failure hospitalized in the 406th Hospital of People’s Liberation Army were in accordance with the diagnostic criteria of the American Heart Association, according to the NYHA classification: 18 cases of grade Ⅳ in cardiac function and 40 cases of grade Ⅲ Cases, Ⅱ grade 32 cases. According to the order of admission, the patients were randomly divided into two groups (n = 45). The control group was treated with conventional drugs and given salt restriction, rest, diuretic, digitalis preparations and oxygen therapy. The treatment group was given Qiliuqiangxin capsule on the basis of routine treatment 4 times a day, Wan Shuangli 20 mg, 3 times a day. Continuous application of 1 month. Heart rate (HR), left ventricular ejection fraction (LVEF), left ventricular end-diastolic diameter (LVEDd), stroke volume (SV) and cardiac index (CI) were measured. Results Compared with the control group, the treatment group decreased HR, increased LVEF, SV, CI, decreased LVEDd and improved cardiac function (P <0.01), and no significant adverse reactions occurred during the treatment. Conclusion Qiliqiangxin capsule combined with Wan Shuangli treatment of chronic congestive heart failure is safe and effective.